#HTAsiaLink
LightNews LightNews
hitap.bsky.social
(cont)
to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by #HTAsiaLink and the C2H in Japan. The AP-7D aims to better reflect values relevant to Asian populations.
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions. Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions. Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions.
August 25, 2025 at 12:20 PM
hitap.bsky.social
(cont)
brought global experts and participants together to explore how to generate evidence on the equity impacts of policy decisions, while addressing gaps, challenges, and country case studies.
Opened with the powerful question “Is Equity Important to You?”, the workshop “Addressing Equity in Health Technology Assessment: Insights and Applications of DCEA in Policy Making”—co-hosted by HITAP with the University of York (England), JIPMER (India), Keio University (Japan), and the University of Melbourne (Australia)—brought global experts and participants together to explore how to generate evidence on the equity impacts of policy decisions, while addressing gaps, challenges, and country case studies. Through interactive discussions and a panel, the session fostered collaboration and shared perspectives, all aimed at strengthening the role of equity in health decision-making. HITAP continues to support equitable health policies across the region. Follow us for more on HITAP’s contributions at the HTAsiaLink 2025, 20–22 August 2025 in Singapore.
August 19, 2025 at 12:01 PM
hitap.bsky.social
(cont)
on data inputs for economic evaluations. The interactive format invited participants to share perspectives and experiences, helping link best-practice guidelines with local contexts to inform stronger policy decisions.
How can we ensure that patients with kidney failure receive life-saving care under Universal Health Coverage (UHC), and that policies are grounded in evidence? At today’s HTAsiaLink 2025 pre-conference, HITAP hosted the workshop “Addressing Kidney Failure under UHC: How to Conduct Economic Evaluation to Inform Policy” to explore this question. Facilitated by Khansa, the workshop guided participants through generating economic evidence for kidney replacement therapy in end-stage kidney disease—starting with Brandon on defining decision problems, Siobhan on selecting approaches and models, and Chotika on data inputs for economic evaluations. The interactive format invited participants to share perspectives and experiences, helping link best-practice guidelines with local contexts to inform stronger policy decisions. This session underscores HITAP’s role in advancing evidence-informed across the region.
August 19, 2025 at 8:49 AM
prof-nancy-devlin.bsky.social
Jan 2025 issue of Value in Health is out now - contents page here 👉 tinyurl.com/VIH-Jan-2025.... Papers include "Good Practices for HTA Guideline Development", a joint ISPOR, HTAi and HTAsiaLink report. tinyurl.com/HTA-Guidelin...
Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force
Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, process, and use, thereby enhanci...
tinyurl.com
January 22, 2025 at 7:28 AM
hitap.bsky.social
📑At the 2025 ISPOR HTA Roundtable – Asia Pacific,
HITAP shared regional efforts with #HTAsiaLink to strengthen HTA capacity, highlighting the HTA Registry for Asia, co-developed for members, by members.

🔗Explore the Asia HTA Registry: bit.ly/4nFcH1R

#HTAsiaLink #Registry #CollaborativeHTA
October 1, 2025 at 8:47 AM
kellyahan.bsky.social
I am pleased to announce that I will be speaking in Plenary 2 at the HTAsiaLink Conference in Singapore next week. I will be discussing the global perspective on the use of AI in #HTA and the assessment of precision medicine. Specific country examples will be provided!

lnkd.in/evD6kh3g
August 13, 2025 at 4:15 PM
hitap.bsky.social
Co-hosted by the Agency for Care Effectiveness (ACE), Singapore, and HTAi Patient & Citizen Involvement in HTA Interest Group (@htaiorg.bsky.social PCIG), the session explored tools and methods to embed patient perspectives in policy, (cont)
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the HTAsiaLink 2025 Conference in Singapore, “Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA. Co-hosted by the Agency for Care Effectiveness (ACE) and HTAi Patient & Citizen Involvement in HTA Interest Group (HTAi PCIG), the session explored tools and methods to embed patient perspectives in policy, and sparked discussion on approaches like patient preference studies to ensure decisions reflect what matters most. HITAP is proud to contribute to advancing patient-centered HTA.
August 19, 2025 at 6:55 AM
hitap.bsky.social
(cont)
on health technology assessment and support evidence-informed health policy in Asia. 🚀

#HITAP #ACE #HTAsiaLink2025 #HTAsiaLink #HealthTechnologyAssessment #HTA
August 28, 2025 at 3:01 AM
hitap.bsky.social
Dr. Yot Teerawattananon, HITAP, delivered opening speech in the Welcome Dinner, setting the tone for meaningful exchanges and collective learning throughout the conference.

🚀 More highlights from the 12th #HTAsiaLink2025 coming soon—stay tuned!

#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA
A Warm Welcome to the 12th #HTAsiaLink2025 in Singapore! Under the theme “Unlocking Value through Health Technology Assessment (HTA) in Asia: Forging Ahead Together,” this year’s gathering celebrates both the 12th HTAsiaLink Conference and the 10th anniversary of Singapore’s Agency for Care Effectiveness (ACE). Together, these milestones reflect a decade of progress in advancing HTA and strengthening collaboration across the region. Dr. Yot Teerawattananon from HITAP, delivered the opening speech in the Welcome Dinner, setting the tone for meaningful exchanges and collective learning throughout the conference.
August 21, 2025 at 4:52 AM
hitap.bsky.social
👏 Thank you to all who joined “Panel PN04” at #HTAi2025 in Buenos Aires!
We shared #HTAsiaLink’s journey & regional efforts on
🔹 #RWE for #HTA in Asia & REALISE Initiative
🔹 ASEAN HTA harmonisation
🔹 Evaluating innovation & policy pathways
🔹 Our future: HTAsiaLink Strategic Plan
Onward together! 🌏
June 20, 2025 at 9:29 AM
hitap.bsky.social
How can we ensure that patients with kidney failure receive life-saving care under Universal Health Coverage (UHC), and that policies are grounded in evidence?
How can we ensure that patients with kidney failure receive life-saving care under Universal Health Coverage (UHC), and that policies are grounded in evidence? At today’s HTAsiaLink 2025 pre-conference, HITAP hosted the workshop “Addressing Kidney Failure under UHC: How to Conduct Economic Evaluation to Inform Policy” to explore this question. Facilitated by Khansa, the workshop guided participants through generating economic evidence for kidney replacement therapy in end-stage kidney disease—starting with Brandon on defining decision problems, Siobhan on selecting approaches and models, and Chotika on data inputs for economic evaluations. The interactive format invited participants to share perspectives and experiences, helping link best-practice guidelines with local contexts to inform stronger policy decisions. This session underscores HITAP’s role in advancing evidence-informed across the region. How can we ensure that patients with kidney failure receive life-saving care under Universal Health Coverage (UHC), and that policies are grounded in evidence? At today’s HTAsiaLink 2025 pre-conference, HITAP hosted the workshop “Addressing Kidney Failure under UHC: How to Conduct Economic Evaluation to Inform Policy” to explore this question. Facilitated by Khansa, the workshop guided participants through generating economic evidence for kidney replacement therapy in end-stage kidney disease—starting with Brandon on defining decision problems, Siobhan on selecting approaches and models, and Chotika on data inputs for economic evaluations. The interactive format invited participants to share perspectives and experiences, helping link best-practice guidelines with local contexts to inform stronger policy decisions. This session underscores HITAP’s role in advancing evidence-informed across the region.
August 19, 2025 at 8:49 AM
hitap.bsky.social
We’re proud to have Mr. Suttavee Rojanasirivanit and the “DCEA Dragon Team” from HITAP presenting a poster titled: “Preparing for Distributional Cost-Effectiveness Analysis: The Crucial Role of Data in Addressing Health Inequities” at the 12th HTAsiaLink Conference 2025 in Singapore!
We’re proud to have Mr. Suttavee Rojanasirivanit and the “DCEA Dragon Team” from HITAP presenting a poster titled: “Preparing for Distributional Cost-Effectiveness Analysis: The Crucial Role of Data in Addressing Health Inequities” at the 12th HTAsiaLink Conference 2025 in Singapore!
August 21, 2025 at 8:35 AM
hitap.bsky.social
Dr. Wanrudee Isaranuwatchai (HITAP), with Prof. Mark Jit (NYU) and Prof. Alex Cook (NUS), explored how epidemiological models can guide policy for emerging and pandemic infectious diseases at Sharing Session 1, #HTAsiaLink2025.
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025. Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
August 21, 2025 at 3:02 AM
hitap.bsky.social
The session highlighted how HTA informs decisions that improve health outcomes, emphasizing patient-centered approaches, sustainable solutions, and translating evidence into actionable policy. ✨

#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #VBHC
August 25, 2025 at 12:37 PM
hitap.bsky.social
(cont)
and the 10th anniversary of Singapore’s Agency for Care Effectiveness (ACE).

Together, these milestones reflect a decade of progress in advancing #HTA and strengthening collaboration across the region.
A Warm Welcome to the 12th #HTAsiaLink2025 in Singapore! Under the theme “Unlocking Value through Health Technology Assessment (HTA) in Asia: Forging Ahead Together,” this year’s gathering celebrates both the 12th HTAsiaLink Conference and the 10th anniversary of Singapore’s Agency for Care Effectiveness (ACE). Together, these milestones reflect a decade of progress in advancing HTA and strengthening collaboration across the region. Dr. Yot Teerawattananon from HITAP, delivered the opening speech in the Welcome Dinner, setting the tone for meaningful exchanges and collective learning throughout the conference.
August 21, 2025 at 4:52 AM
hitap.bsky.social
The session highlighted the need for clear standards to make models more useful for HTA and policy decisions.

#HITAP #HTAsiaLink2025 #HTAsiaLink #HealthTechnologyAssessment #HTA
Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025. Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025. Dr. Wanrudee Isaranuwatchai (HITAP), along with Prof. Mark Jit (New York University) and Prof. Alex Cook (NUS), speakers at Sharing Session 1 at #HTAsiaLink2025, explored how epidemiological models can guide policy for emerging and pandemic infectious diseases. The session also highlighted the need for clear standards in evidence and reporting to make models more useful for health technology assessment (HTA) and policy decisions. Stronger standards mean better evidence and greater impact for populations across Asia. Stay tuned for HITAP’s contribution at the HTAsiaLink Conference 2025.
August 21, 2025 at 3:02 AM
hitap.bsky.social
(cont)
“Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA.
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the HTAsiaLink 2025 Conference in Singapore, “Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA. Co-hosted by the Agency for Care Effectiveness (ACE) and HTAi Patient & Citizen Involvement in HTA Interest Group (HTAi PCIG), the session explored tools and methods to embed patient perspectives in policy, and sparked discussion on approaches like patient preference studies to ensure decisions reflect what matters most. HITAP is proud to contribute to advancing patient-centered HTA.
August 19, 2025 at 6:55 AM
hitap.bsky.social
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the #HTAsiaLink2025, (cont)
Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the HTAsiaLink 2025 Conference in Singapore, “Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA. Co-hosted by the Agency for Care Effectiveness (ACE) and HTAi Patient & Citizen Involvement in HTA Interest Group (HTAi PCIG), the session explored tools and methods to embed patient perspectives in policy, and sparked discussion on approaches like patient preference studies to ensure decisions reflect what matters most. HITAP is proud to contribute to advancing patient-centered HTA. Patients bring unique perspectives and experiences that can strengthen health technology assessment (HTA). Three HITAP staff — Ms. Jiratorn Sutawong, Ms. Supasuda Posoree, and Ms. Siriyada Kitbamrung — spoke at the pre-conference workshop at the HTAsiaLink 2025 Conference in Singapore, “Voices to Action – The Value of Involving Patients in HTA,” sharing insights from Thailand on patient involvement in HTA. Co-hosted by the Agency for Care Effectiveness (ACE) and HTAi Patient & Citizen Involvement in HTA Interest Group (HTAi PCIG), the session explored tools and methods to embed patient perspectives in policy, and sparked discussion on approaches like patient preference studies to ensure decisions reflect what matters most. HITAP is proud to contribute to advancing patient-centered HTA.
August 19, 2025 at 6:55 AM
hitap.bsky.social
🔹 This session underscores HITAP's role in advancing evidence-informed across the region.

This is just the beginning. Stay tuned for more updates from #HTAsiaLink2025 🚀

#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #Kidneydisease
August 19, 2025 at 8:49 AM
hitap.bsky.social
Through interactive discussions and a panel, the session fostered collaboration and shared perspectives, all aimed at strengthening the role of equity in health decision-making. 🌏

✨ HITAP continues to support equitable health policies across the region.
Opened with the powerful question “Is Equity Important to You?”, the workshop “Addressing Equity in Health Technology Assessment: Insights and Applications of DCEA in Policy Making”—co-hosted by HITAP with the University of York (England), JIPMER (India), Keio University (Japan), and the University of Melbourne (Australia)—brought global experts and participants together to explore how to generate evidence on the equity impacts of policy decisions, while addressing gaps, challenges, and country case studies. Through interactive discussions and a panel, the session fostered collaboration and shared perspectives, all aimed at strengthening the role of equity in health decision-making. HITAP continues to support equitable health policies across the region. Follow us for more on HITAP’s contributions at the HTAsiaLink 2025, 20–22 August 2025 in Singapore.
August 19, 2025 at 12:01 PM
hitap.bsky.social
The future of HTA in Asia-Pacific is here! 🌏
🎊#HTAsiaLink l#AsiaPacificaunches its 2025–2030 Strategic Plan—advancing evidence-informed decisions with 50+ members across 20 countries.
📥Explore our 5 key goals and download now: htasialink.com/projects/90-...
May 13, 2025 at 4:06 AM
hitap.bsky.social
New from HTAsiaLink: the Strategic Plan Report
A look behind the evidence, insights, and collaboration shaping our 2025–2030 roadmap for advancing HTA and evidence-informed policy in Asia-Pacific.

📘 Read more: htasialink.com/projects/91-...

#HTAsiaLink #HTA #StrategicPlan #EvidenceInformedPolicy
HTAsiaLink Strategic Plan Report: Insights and Evidence Behind Our Roadmap. Our 2025–2030 Strategic Plan was built on collaboration, evidence, and engagement. The new Strategic Plan Report takes you behind the scenes to show how member feedback, regional consultations, and research shaped every goal and action in the Plan. This report is a practical resource for networks and partners seeking to align strategy with evidence and strengthen collaboration across Asia-Pacific. Read the full report: https://htasialink.com/projects/91-htasialink-strategic-plan-report-insights-and-evidence-behind-our-roadmap
October 25, 2025 at 4:18 AM
hitap.bsky.social
📌 Follow us for more insights and highlights from HITAP at #HTAsiaLink2025.

#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #AP-7D #tool #research #survey #HealthOutcome
August 25, 2025 at 12:20 PM
hitap.bsky.social
Your work continues to inspire and strengthen our collective mission of improving health through evidence. 🌏✨

#HITAP #HTAsiaLink #HealthTechnologyAssessment #HTA #AcademicExcellence #TeamHITAP
August 22, 2025 at 9:20 AM
hitap.bsky.social
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 (cont)
Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions. Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions. Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions. Dr. Yot Teerawattananon from HITAP joined Prof. Nan Luo (NUS), Dr. Morii Yasuhiro (Center for Outcomes Research and Economic Evaluation for Health: C2H), and Prof. Jeonghoon Ahn (Ewha Womans University) in Sharing Session 2 at #HTAsiaLink2025 to discuss the Asia-Preference-Based Measure-7 Dimension (AP-7D)—a novel, region-specific preference-based measure (PBM) developed by HTAsiaLink and the Center for Outcomes Research and Economic Evaluation for Health (C2H) in Japan. The AP-7D aims to better reflect values relevant to Asian populations. The session focused ongoing valuation surveys across countries and the recent updates on AP-7D, paving the way for a deeper understanding of how health preferences differ across the region and how these insights can inform HTA and policy decisions.
August 25, 2025 at 12:20 PM